Kontroliranje i optimizacija hemostaze

Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network

Izvor‎: N Engl J Med 2017;376(2):136-48.

Indeks‎: PubMed 27774838

DOI‎: 10.1056/NEJMoa1606424

http://www.ncbi.nlm.nih.gov/pubmed/27774838 (otvara se novi prozor)

Aprotinin for patients exposed to clopidogrel before off-pump coronary bypass. (otvara se novi prozor)

Nurözler F, Kutlu T, Küçük G.

Izvor‎: Asian Cardiovasc Thorac Ann 2008;16(6):483-7.

Indeks‎: PubMed 18984759

DOI‎: 10.1177/021849230801600611

https://www.ncbi.nlm.nih.gov/pubmed/18984759 (otvara se novi prozor)

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. (otvara se novi prozor)

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

Izvor‎: JAMA Surg 2013;148(6):538-47.

Indeks‎: PubMed 23426385

DOI‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 (otvara se novi prozor)

Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery: The OPTIMAL randomized clinical trial. (otvara se novi prozor)

Shi J, Zhou C, Pan W, Sun H, Liu S, Feng W, Wang W, Cheng Z, Wang Y, Zheng Z

Izvor‎: JAMA. 2022;328(4):336-47.

Indeks‎: PubMed 35881121

DOI‎: 10.1001/jama.2022.10725

https://pubmed.ncbi.nlm.nih.gov/35881121/ (otvara se novi prozor)

Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. (otvara se novi prozor)

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, Liu M, Chen L, Li L.

Izvor‎: Anesth Analg 2012;115(2):239-43.

Indeks‎: PubMed 21737704

DOI‎: 10.1213/ANE.0b013e3182264a11

https://www.ncbi.nlm.nih.gov/pubmed/21737704 (otvara se novi prozor)

Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery. (otvara se novi prozor)

Wang X, Zheng Z, Ao H, Zhang S, Wang Y, Zhang H, Hu S.

Izvor‎: Ann Thorac Surg 2010;89(5):1489-95.

Indeks‎: PubMed 20417766

DOI‎: 10.1016/j.athoracsur.2010.02.006

https://www.ncbi.nlm.nih.gov/pubmed/20417766 (otvara se novi prozor)

Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study. (otvara se novi prozor)

Øvrum E, Tangen G, Tølløfsrud S, Ringdal MA, Øystese R, Istad R.

Izvor‎: Interact Cardiovasc Thorac Surg 2010;10(4):545-8.

Indeks‎: PubMed 20067988

DOI‎: 10.1510/icvts.2009.226613

https://www.ncbi.nlm.nih.gov/pubmed/20067988 (otvara se novi prozor)

Rekombinirani aktivirani faktor VII (rFVIIa)

Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa? (otvara se novi prozor)

Ballen J, Raabe M, Muirhead B.

Izvor‎: Can J Anaesth 2006;53(4):353-6.

Indeks‎: PubMed 16575032

DOI‎: 10.1007/BF03022498

https://www.ncbi.nlm.nih.gov/pubmed/16575032 (otvara se novi prozor)

Use of recombinant activated factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications. (otvara se novi prozor)

Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.

Izvor‎: Transfusion 2013;53(4):798-804.

Indeks‎: PubMed 22845023

DOI‎: 10.1111/j.1537-2995.2012.03801.x

https://www.ncbi.nlm.nih.gov/pubmed/22845023 (otvara se novi prozor)

Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. (otvara se novi prozor)

Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.

Izvor‎: Ann Thorac Surg 2008;85(3):836-44.

Indeks‎: PubMed 18291152

DOI‎: 10.1016/j.athoracsur.2007.06.076

https://www.ncbi.nlm.nih.gov/pubmed/18291152 (otvara se novi prozor)

Repeat cardiac surgery in a Jehovah's Witness patient with thrombocytopenia. (otvara se novi prozor)

Elmistekawy E, Lapierre H, Bourke M, Dennie C, Labinaz M, Ruel M.

Izvor‎: Can J Cardiol 2011;27(6):869.e7-8.

Indeks‎: PubMed 21983113

DOI‎: 10.1016/j.cjca.2011.07.632

https://www.ncbi.nlm.nih.gov/pubmed/21983113 (otvara se novi prozor)

Off-label use of recombinant activated factor VII for cardiac surgical bleeding. (otvara se novi prozor)

Flynn BC, Steiner ME, Mazzeffi M

Izvor‎: Anesthesiology. 2023 1;139(2):197-210.

Indeks‎: PubMed 37155359

DOI‎: 10.1097/ALN.0000000000004569

https://pubmed.ncbi.nlm.nih.gov/37155359/ (otvara se novi prozor)

Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. (otvara se novi prozor)

Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA.

Izvor‎: Circulation 2009;120(1):21-7.

Indeks‎: PubMed 19546387

DOI‎: 10.1161/CIRCULATIONAHA.108.834275

https://www.ncbi.nlm.nih.gov/pubmed/19546387 (otvara se novi prozor)

Intraoperative use of recombinant activated factor VII during complex aortic surgery. (otvara se novi prozor)

Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA.

Izvor‎: J Thorac Cardiovasc Surg 2012;143(5):1198-204.

Indeks‎: PubMed 22285329

DOI‎: 10.1016/j.jtcvs.2012.01.004

https://www.ncbi.nlm.nih.gov/pubmed/22285329 (otvara se novi prozor)

Off-label use of recombinant human factor VIIa. (otvara se novi prozor)

Goodnough LT, Levy JH.

Izvor‎: Ann Thorac Surg 2014;98(2):393-5.

Indeks‎: PubMed 25087781

DOI‎: 10.1016/j.athoracsur.2014.06.007

https://www.ncbi.nlm.nih.gov/pubmed/25087781 (otvara se novi prozor)

Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7). (otvara se novi prozor)

Hacquard M, Durand M, Lecompte T, Boini S, Briançon S, Carteaux JP.

Izvor‎: Eur J Cardiothorac Surg 2011;40(6):1320-7.

Indeks‎: PubMed 21550261

DOI‎: 10.1016/j.ejcts.2011.03.032

https://www.ncbi.nlm.nih.gov/pubmed/21550261 (otvara se novi prozor)

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. (otvara se novi prozor)

Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM.

Izvor‎: Circulation 2008;118(4):331-8.

Indeks‎: PubMed 18606914

DOI‎: 10.1161/CIRCULATIONAHA.108.764308

https://www.ncbi.nlm.nih.gov/pubmed/18606914 (otvara se novi prozor)

Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery. (otvara se novi prozor)

Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.

Izvor‎: J Vasc Surg 2011;53(4):1032-7.

Indeks‎: PubMed 21215579

DOI‎: 10.1016/j.jvs.2010.07.075

https://www.ncbi.nlm.nih.gov/pubmed/21215579 (otvara se novi prozor)

Use of activated recombinant factor VII in severe bleeding—evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding. (otvara se novi prozor)

Lau P, Ong V, Tan WT, Koh PL, Hartman M.

Izvor‎: Transfus Med Hemother 2012;39(2):139-50.

Indeks‎: PubMed 22670132

DOI‎: 10.1159/000338034

https://www.ncbi.nlm.nih.gov/pubmed/22670132 (otvara se novi prozor)

Recombinant activated factor VII for postoperative hemorrhage following repair of acute type A aortic dissection. (otvara se novi prozor)

Lehr EJ, Alford TJ, Wang SH.

Izvor‎: Heart Surg Forum 2010;13(5):E275-9.

Indeks‎: PubMed 20961825

DOI‎: 10.1532/HSF98.20101027

https://www.ncbi.nlm.nih.gov/pubmed/20961825 (otvara se novi prozor)

Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes. (otvara se novi prozor)

Masud F, Bostan F, Chi E, Pass SE, Samir H, Stuebing K, Liebl MG.

Izvor‎: J Cardiothorac Vasc Anesth 2009;23(1):28-33.

Indeks‎: PubMed 18948033

DOI‎: 10.1053/j.jvca.2008.08.003

https://www.ncbi.nlm.nih.gov/pubmed/18948033 (otvara se novi prozor)

Recombinant activated factor VII significantly reduces transfusion requirements in cardiothoracic surgery. (otvara se novi prozor)

Omar HR, Enten G, Karlnoski R, Ching YH, Mangar D, Camporesi EM.

Izvor‎: Drugs R D 2015;15(2):187-94.

Indeks‎: PubMed 25862216

DOI‎: 10.1007/s40268-015-0093-9

https://www.ncbi.nlm.nih.gov/pubmed/25862216 (otvara se novi prozor)

Hemostatic management of severe thrombocytopenia in a patient undergoing pulmonic valve replacement. (otvara se novi prozor)

Tanaka KA, Li P, McHugh SM, Subramaniam K.

Izvor‎: A A Case Rep 2015;5(1):3-5.

Indeks‎: PubMed 26125690

DOI‎: 10.1213/XAA.0000000000000166

https://www.ncbi.nlm.nih.gov/pubmed/26125690 (otvara se novi prozor)

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). (otvara se novi prozor)

Tanaka KA, Waly AA, Cooper WA, Levy JH.

Izvor‎: Anesthesiology 2003;98(6):1513-5.

Indeks‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668 (otvara se novi prozor)

Recombinant activated factor VII in cardiac surgery: a systematic review. (otvara se novi prozor)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Izvor‎: Ann Thorac Surg 2007;83(2):707-14.

Indeks‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (otvara se novi prozor)

Koncentrati faktora zgrušavanja

Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion. (otvara se novi prozor)

Alberts M, Bandarenko N, Gaca J, Lockhart E, Milano C, Alexander S, Linder D, Lombard FW, Welsby IJ.

Izvor‎: Transfusion 2014;54(5):1348-57.

Indeks‎: PubMed 24898456

DOI‎: 10.1111/trf.12463

https://www.ncbi.nlm.nih.gov/pubmed/24898456 (otvara se novi prozor)

Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. (otvara se novi prozor)

Arnékian V, Camous J, Fattal S, Rézaiguia-Delclaux S, Nottin R, Stéphan F.

Izvor‎: Interact Cardiovasc Thorac Surg 2012;15(3):382-9.

Indeks‎: PubMed 22623627

DOI‎: 10.1093/icvts/ivs224

https://www.ncbi.nlm.nih.gov/pubmed/22623627 (otvara se novi prozor)

Reducing blood transfusion in aortic surgery: a novel approach. (otvara se novi prozor)

Birla R, Nawaytou O, Shaw M, Jackson A, Mills K, Kuduvalli M, Field M, Agarwal S

Izvor‎: Ann Thorac Surg 2019;108(5):1369-75.

Indeks‎: PubMed 31255616

DOI‎: 10.1016/j.athoracsur.2019.04.127

https://www.ncbi.nlm.nih.gov/pubmed/31255616 (otvara se novi prozor)

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient. (otvara se novi prozor)

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA.

Izvor‎: Ann Thorac Surg 2009;88(5):1666-8.

Indeks‎: PubMed 19853132

DOI‎: 10.1016/j.athoracsur.2009.03.095

https://www.ncbi.nlm.nih.gov/pubmed/19853132 (otvara se novi prozor)

Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery. (otvara se novi prozor)

Cappabianca G, Mariscalco G, Biancari F, Maselli D, Papesso F, Cottini M, Crosta S, Banescu S, Ahmed AB, Beghi C.

Izvor‎: Crit Care 2016;20:5.

Indeks‎: PubMed 26738468

DOI‎: 10.1186/s13054-015-1172-6

https://www.ncbi.nlm.nih.gov/pubmed/26738468 (otvara se novi prozor)

Bloodless orthotopic heart transplantation in a Jehovah's Witness. (otvara se novi prozor)

Dallas T, Welsby I, Bottiger B, Milano C, Daneshmand M, Guinn N.

Izvor‎: A A Case Rep 2015;4(10):140-2.

Indeks‎: PubMed 25974419

DOI‎: 10.1213/XAA.0000000000000067

https://www.ncbi.nlm.nih.gov/pubmed/25974419 (otvara se novi prozor)

State of the art - how I manage coagulopathy in cardiac surgery patients. (otvara se novi prozor)

Davidson S.

Izvor‎: Br J Haematol 2014;164(6):779-89.

Indeks‎: PubMed 24450971

DOI‎: 10.1111/bjh.12746

https://www.ncbi.nlm.nih.gov/pubmed/24450971 (otvara se novi prozor)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (otvara se novi prozor)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Izvor‎: Anesthesiology 2011;115(6):1179-91.

Indeks‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (otvara se novi prozor)

Comparison of 4-factor prothrombin complex concentrate with frozen plasma for management of hemorrhage during and after cardiac surgery: a randomized pilot trial. (otvara se novi prozor)

Karkouti K, Bartoszko J, Grewal D, Bingley C, Armali C, Carroll J, Hucke HP, Kron A, McCluskey SA, Rao V, Callum J

Izvor‎: JAMA Netw Open 2021;4(4):e213936.

Indeks‎: PubMed 33792729

DOI‎: 10.1001/jamanetworkopen.2021.3936

https://www.ncbi.nlm.nih.gov/pubmed/33792729 (otvara se novi prozor)

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. (otvara se novi prozor)

Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A.

Izvor‎: Thromb Haemost 2009;102(1):137-44.

Indeks‎: PubMed 19572078

DOI‎: 10.1160/TH08-09-0587

https://www.ncbi.nlm.nih.gov/pubmed/19572078 (otvara se novi prozor)

Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. (otvara se novi prozor)

Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M.

Izvor‎: J Thorac Cardiovasc Surg 2013;145(3 Suppl):S178-85.

Indeks‎: PubMed 23410777

DOI‎: 10.1016/j.jtcvs.2012.12.083

https://www.ncbi.nlm.nih.gov/pubmed/23410777 (otvara se novi prozor)

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. (otvara se novi prozor)

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Izvor‎: Anesthesiology 2013;118(1):40-50.

Indeks‎: PubMed 23249928

DOI‎: 10.1097/ALN.0b013e3182715d4d

https://www.ncbi.nlm.nih.gov/pubmed/23249928 (otvara se novi prozor)

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. (otvara se novi prozor)

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

Izvor‎: J Am Heart Assoc 2015;4(6):e002066.

Indeks‎: PubMed 26037084

DOI‎: 10.1161/JAHA.115.002066

https://www.ncbi.nlm.nih.gov/pubmed/26037084 (otvara se novi prozor)

Fibrinogen supplementation after cardiac surgery: insights from the zero-plasma trial (ZEPLAST). (otvara se novi prozor)

Ranucci M, Baryshnikova E.

Izvor‎: Br J Anaesth 2016;116(5):618-23.

Indeks‎: PubMed 26893405

DOI‎: 10.1093/bja/aev539

https://www.ncbi.nlm.nih.gov/pubmed/26893405 (otvara se novi prozor)

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate. (otvara se novi prozor)

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

Izvor‎: Can J Anaesth 2012;59(3):299-303.

Indeks‎: PubMed 22161243

DOI‎: 10.1007/s12630-011-9647-7

https://www.ncbi.nlm.nih.gov/pubmed/22161243 (otvara se novi prozor)

Prothrombin complex concentrate in cardiac surgery: a systematic review and meta-analysis. (otvara se novi prozor)

Roman M, Biancari F, Ahmed AB, Agarwal S, Hadjinikolaou L, Al-Sarraf A, Tsang G, Oo AY, Field M, Santini F, Mariscalco G

Izvor‎: Ann Thorac Surg 2019;107(4):1275-83.

Indeks‎: PubMed 30458156

DOI‎: 10.1016/j.athoracsur.2018.10.013

https://www.ncbi.nlm.nih.gov/pubmed/30458156 (otvara se novi prozor)

Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. (otvara se novi prozor)

Sniecinski RM, Chen EP, Levy JH, Szlam F, Tanaka KA.

Izvor‎: Anesth Analg 2007;104(4):763-5.

Indeks‎: PubMed 17377078

DOI‎: 10.1213/01.ane.0000250913.45299.f3

https://www.ncbi.nlm.nih.gov/pubmed/17377078 (otvara se novi prozor)

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products. (otvara se novi prozor)

Solomon C, Schöchl H, Hanke A, Calatzis A, Hagl C, Tanaka K, Rahe-Meyer N.

Izvor‎: Scand J Clin Lab Invest 2012;72(2):121-8.

Indeks‎: PubMed 22233480

DOI‎: 10.3109/00365513.2011.643818

https://www.ncbi.nlm.nih.gov/pubmed/22233480 (otvara se novi prozor)

Dezmoprezin

Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. (otvara se novi prozor)

Hanke AA, Dellweg C, Kienbaum P, Weber CF, Görlinger K, Rahe-Meyer N.

Izvor‎: Anaesthesia 2010;65(7):688-91.

Indeks‎: PubMed 20477783

DOI‎: 10.1111/j.1365-2044.2010.06367.x

https://www.ncbi.nlm.nih.gov/pubmed/20477783 (otvara se novi prozor)

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. (otvara se novi prozor)

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

Izvor‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

Indeks‎: PubMed 18068065

DOI‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 (otvara se novi prozor)

Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults. (otvara se novi prozor)

Wademan BH, Galvin SD.

Izvor‎: Interact Cardiovasc Thorac Surg 2014;18(3):360-70.

Indeks‎: PubMed 24263581

DOI‎: 10.1093/icvts/ivt491

https://www.ncbi.nlm.nih.gov/pubmed/24263581 (otvara se novi prozor)

A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. (otvara se novi prozor)

Weber CF, Dietrich W, Spannagl M, Hofstetter C, Jámbor C.

Izvor‎: Anesth Analg 2010;110(3):702-7.

Indeks‎: PubMed 20042444

DOI‎: 10.1213/ANE.0b013e3181c92a5c

https://www.ncbi.nlm.nih.gov/pubmed/20042444 (otvara se novi prozor)

Topikalna hemostatička sredstva

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (otvara se novi prozor)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Izvor‎: Ann Surg 2010;251(2):217-28.

Indeks‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (otvara se novi prozor)

A review of topical hemostatic agents for use in cardiac surgery. (otvara se novi prozor)

Barnard J, Millner R.

Izvor‎: Ann Thorac Surg 2009;88(4):1377-83.

Indeks‎: PubMed 19766855

DOI‎: 10.1016/j.athoracsur.2009.02.092

https://www.ncbi.nlm.nih.gov/pubmed/19766855 (otvara se novi prozor)

Armentarium of topical hemostatic products in cardiovascular surgery: an update. (otvara se novi prozor)

Forcillo J, Perrault LP.

Izvor‎: Transfus Apher Sci 2014;50(1):26-31.

Indeks‎: PubMed 24412443

DOI‎: 10.1016/j.transci.2013.12.009

https://www.ncbi.nlm.nih.gov/pubmed/24412443 (otvara se novi prozor)

A novel reverse thermosensitive polymer to achieve temporary atraumatic vessel occlusion in infra-popliteal bypasses. (otvara se novi prozor)

Mani K, Campbell A, Fitzpatrick J, Modarai B, Carrell T, Rashid H, Zayed H.

Izvor‎: Eur J Vasc Endovasc Surg 2013;45(1):51-6.

Indeks‎: PubMed 23134676

DOI‎: 10.1016/j.ejvs.2012.10.008

https://www.ncbi.nlm.nih.gov/pubmed/23134676 (otvara se novi prozor)

Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. (otvara se novi prozor)

Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, Koster A, Mackenzie GS, Murphy GJ, Spiess B, Ad N.

Izvor‎: Innovations (Phila) 2012;7(4):229-41.

Indeks‎: PubMed 23123988

DOI‎: 10.1097/IMI.0b013e3182747699

https://www.ncbi.nlm.nih.gov/pubmed/23123988 (otvara se novi prozor)

Control of troublesome bleeding during repair of acute type A dissection with use of modified rapid deployment hemostat (MRDH). (otvara se novi prozor)

Salerno TA, Gaughan C, Suarez M, Panos AL.

Izvor‎: J Card Surg 2009;24(6):722-4.

Indeks‎: PubMed 20078720

DOI‎: 10.1111/j.1540-8191.2009.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/20078720 (otvara se novi prozor)

Topical haemostatic agents. (otvara se novi prozor)

Seyednejad H, Imani M, Jamieson T, Seifalian AM.

Izvor‎: Br J Surg 2008;95(10):1197-225.

Indeks‎: PubMed 18763249

DOI‎: 10.1002/bjs.6357

https://www.ncbi.nlm.nih.gov/pubmed/18763249 (otvara se novi prozor)

Viskoelastični testovi za otkrivanje kirurškog ili koagulopatijskog krvarenja

An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. (otvara se novi prozor)

Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W.

Izvor‎: Transfus Med 2006;16(1):31-9.

Indeks‎: PubMed 16480437

DOI‎: 10.1111/j.1365-3148.2006.00645.x

https://www.ncbi.nlm.nih.gov/pubmed/16480437 (otvara se novi prozor)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (otvara se novi prozor)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Izvor‎: Anesthesiology 2011;115(6):1179-91.

Indeks‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (otvara se novi prozor)

Management of hemorrhage in cardiothoracic surgery. (otvara se novi prozor)

Görlinger K, Shore-Lesserson L, Dirkmann D, Hanke AA, Rahe-Meyer N, Tanaka KA.

Izvor‎: J Cardiothorac Vasc Anesth 2013;27(4 Suppl):S20-34.

Indeks‎: PubMed 23910533

DOI‎: 10.1053/j.jvca.2013.05.014

https://www.ncbi.nlm.nih.gov/pubmed/23910533 (otvara se novi prozor)

Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. (otvara se novi prozor)

Weber CF, Görlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K.

Izvor‎: Anesthesiology 2012;117(3):531-47.

Indeks‎: PubMed 22914710

DOI‎: 10.1097/ALN.0b013e318264c644

https://www.ncbi.nlm.nih.gov/pubmed/22914710 (otvara se novi prozor)

KARDIOTORAKALNA I VASKULARNA KIRURGIJA

Kontroliranje i optimizacija hemostaze

hrvatski

Kontroliranje i optimizacija hemostaze

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Antifibrinolitička sredstva

Rekombinirani aktivirani faktor VII (rFVIIa)

Koncentrati faktora zgrušavanja

Dezmoprezin

Topikalna hemostatička sredstva

Viskoelastični testovi za otkrivanje kirurškog ili koagulopatijskog krvarenja

Izaberi svoj jezik

Podijeli